Image courtesy of Ceribell Inc.
Ceribell Inc., the company that set out to simplify bedside electroencephalogram (EEG) monitoring with its Ceribell Rapid Response EEG and took home the 2019 Medical Design Excellence Awards Best-in-Show award, has just launched Clarity, a new 24/7 bedside EEG monitoring and alerting technology. The company made the announcement at the American Epileptology Society Annual Meeting.
Ceribell Rapid Response EEG was designed to ease EEG setup and triage for patients with suspicion of seizure, and application does not require an EEG technician. In addition to winning the MDEA Best in Show, the system was also recognized with a gold award in the Testing and Diagnostic Products and Systems category and a silver award in the Non-Surgical Hospital Supplies and Equipment category. It consists of a 10-electrode (8-channel) headband, an EEG recorder with the Brain Stethoscope feature, and a cloud portal for continuous seizure monitoring, EEG data storing, and remote EEG reviewing. With the Brain Stethoscope and Clarity features, EEG interpretation for spot-checking and continuous seizure detection are possible in just seconds, the company reported in a news release.
"As we continue to drive innovation in the field of encephalography, we are excited to bring the Clarity technology to our Rapid Response EEG System for our customers," stated Jane Chao, CEO, Ceribell, in the release. "When it comes to EEG, there are significant unmet needs for greater access, efficiency, and cost-effectiveness. Clarity will empower hospitals to have the very best in 24/7 acute care EEG capability, at a fraction of the cost of conventional systems. For the first time, it is possible for physicians to detect non-convulsive status epilepticus within minutes instead of waiting hours or days, allowing them to provide the best care available so they can minimize secondary brain injury."
The company explained that non-convulsive seizures are common in critically ill patients, and most can only be detected using EEG. Such seizures, however, could put patients at risk for permanent brain injury, higher risk of morbidity and mortality, and longer hospital stay. Consequently, Neurocritical Care Society guidelines advise that EEG be started within 15-60 minutes of suspected status epilepticus.
"Ceribell with Clarity can detect and rule out seizure activity more efficiently, even when neurologists are not immediately available," according to a video posted to Ceribell's site.
The Ceribell EEG System received FDA 510(k) clearance in 2017 and is commercially available in the United States.